The FDA approved Ultragenyx Pharmaceutical’s Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for children with ...
Trust in the pharma industry has been steadily declining among consumers, regardless of political affiliation. A 2023 study ...
Voters will weigh in on abortion in Missouri, and three other states, in the November general election. Missouri is also one ...
For Hispanic Heritage Month, marketing leaders from Cologuard and MetroPlusHealth explain why culturally relevant healthcare ...
In this episode, industry leaders from Syneos Health, Joe Daley and Matthew Snodgrass, introduce a new definition of success ...
Hundreds of marketing, comms and advertising pros will join us in New York City on November 12. You’ll want to be among them.
The multiyear deal embeds real-time pricing into Epocrates' drug content. Executives call the launch a baseline and pitch it ...
The drugmaker designed “Because Ibsrela Can” with clear, static safety visuals after studying the agency’s recent objections ...
Investors eye osteoporosis; Bipartisan scrutiny of drugmakers, insurers and PBMs; U.S. scales back ACA coverage.
Moran referred to “change fatigue” at a morning panel that also featured 2025 MM+M Awards jury chair Meghan Rivera, VP, ...
About half of rural American voters believe the economy is worse off now than when President Donald Trump returned to office, ...
AstraZeneca’s campaign supporting its asthma and COPD treatment Breztri features several AI-generated elements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results